Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 4Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 7Lymphoma, Large B-Cell, Diffuse 6Osteosarcoma 3Lymphoma, B-Cell 3Sarcoma, Ewing 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Penile Neoplasms 2Neurofibrosarcoma 2Liposarcoma 2Hemangiosarcoma 2Fibrosarcoma 2Burkitt Lymphoma 2Wilms Tumor 1Vascular Neoplasms 1Teratoma 1Solitary Fibrous Tumors 1Smooth Muscle Tumor 1Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1Sarcoma, Clear Cell 1Rhabdomyosarcoma 1Recurrence 1Prostatic Neoplasms 1Pleuropulmonary blastoma 1Neuroblastoma 1Nerve Sheath Neoplasms 1Neoplasms, Adipose Tissue 1Neoplasm Metastasis 1Myoepithelioma 1Lymphoma, T-Cell, Peripheral 1

Interventions

Temozolomide 6Cyclophosphamide 5cabozantinib 4Vincristine 4fludarabine 3Radiotherapy 3Irinotecan 3liposomal doxorubicin 2irinotecan sucrosofate 2Zoledronic Acid 2Topotecan 2Specimen Handling 2PM 01183 2Ifosfamide 2Etoposide 2Eflornithine 2Drug Therapy 2Doxorubicin 2trilaciclib 1trifluridine tipiracil drug combination 1talazoparib 1silmitasertib 1romiplostim 1regorafenib 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1naxitamab 1fluzoparib 1fludarabine phosphate 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Sarcoma, Ewing × Ifosfamide × Clear all
NCT07321912 2026-05-26

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Milton S. Hershey Medical Center

Phase 2 Recruiting
406 enrolled
Sarcoma

Sarcoma, Ewing, Osteosarcoma

NCT07194044 2026-05-15

METTSEO

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting
15 enrolled
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡